logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (iii) All outpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge knownAge not known
Opiates5.940.527.513.26.73.41.61.222.414166432422
Cocaine5.642.825.912.26.93.61.81.222.34807812199
Stimulants12.456.018.46.73.01.80.80.919.9112793834
Hypnotics and sedatives13.625.717.112.110.07.65.78.125.950951897
Hallucinogens6.852.723.09.04.32.01.31.020.9799474
Volatile substances18.774.73.31.20.90.70.20.317.41009344
Cannabis 36.052.38.21.90.80.40.20.317.06704231200
Other substances 24.840.013.17.35.13.62.63.521.128681360
Total13.844.321.89.95.22.71.31.121.027783483730
 

Notes:

Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LU, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-107 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI — outpatient treatment centres.

Page last updated: Monday, 09 July 2012